Enablement of RAASi therapy in HF using novel potassium binders10' education - Mar. 8, 2022 - Prof. Javed Butler, MD (Jackson, MS, USA) and prof. Giuseppe Rosano, MD, PhD (London, UK)
Video navigation menu
- The problem of RAASi therapy and incidence of hyperkalemia 00:50
- Study data on potassium binders 05:02
- Considerations for long term management with potassium binders 07:35
- Take-home message 11:33
This video was developed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.
Javed Butler, MD is professor and chairman of the Department of Medicine at the University of Mississippi, Jackson, MS, USA.
Giuseppe Rosano, MD, PhD is professor of cardiology and consultant cardiologist at St. George's University Hospitals in London, UK.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of EPCCS.
Funding for this educational program was provided by and independent educational grant from Vifor Pharma.
Click here for the CME course on ReachMD
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: